Macrophages As a Therapeutic Target to Promote Diabetic Wound Healing Publisher Pubmed



Sharifiaghdam M^{1, 2} ; Shaabani E^{1, 2} ; Faridimajidi R² ; De Smedt SC¹ ; Braeckmans K^{1, 3} ; Fraire JC¹ Show Affiliations
Source: Molecular Therapy Published:2022

Abstract

It is well‏ ‏established that macrophages are key regulators of wound healing, displaying impressive plasticity and an evolving phenotype, from an aggressive pro-inflammatory or “M1” phenotype to a pro-healing or “M2” phenotype, depending on the wound healing stage, to ensure proper healing. Because dysregulated macrophage responses have been linked to impaired healing of diabetic wounds, macrophages are being considered as a therapeutic target for improved wound healing. In this review, we first discuss the role of macrophages in a normal skin wound healing process and discuss the aberrations that occur in macrophages under diabetic conditions. Next we provide an overview of recent macrophage-based therapeutic approaches, including delivery of ex-vivo-activated macrophages and delivery of pharmacological strategies aimed at eliminating or re-educating local skin macrophages. In particular, we focus on strategies to silence key regulator genes to repolarize wound macrophages to the M2 phenotype, and we provide a discussion of their potential future clinical translation. © 2022 The American Society of Gene and Cell Therapy